心身症状量表在抑郁发作患者中的临床应用研究-东南大学学报医学版

心身症状量表在抑郁发作患者中的临床应用研究

作者：游林林¹ 李磊² 陈青松³ 杨忠⁴ 潘惠⁴ 王明⁴ 胡长春⁵ 沈仲夏⁶ 吴江² 袁勇贵¹

单位：1. 东南大学附属中大医院心理精神科, 江苏南京 210009;
2. 连云港市第四人民医院, 江苏连云港 222023;
3. 靖江市第二人民医院, 江苏靖江 214500;
4. 常熟市第三人民医院, 江苏常熟 215501;
5. 杭州市第一人民医院精神科, 浙江杭州 310000;
6. 湖州市第

关键词：抑郁发作心身症状量表抑郁焦虑躯体症状

分类号：R749.41

出版年·卷·期（页码）：2022·41·第三期（439-443）

摘要：

目的：使用心身症状量表（PSSS）、9条目患者健康问卷（PHQ-9）、广泛性焦虑障碍量表（GAD-7）及患者健康问卷躯体症状群量表（PHQ-15）同时评估抑郁发作患者，以探讨PSSS评估抑郁、焦虑和心身症状的效能。方法：选取193例抑郁发作患者，分别于入组当天及2周末采用PSSS、PHQ-9、GAD-7及PHQ-15评估抑郁、焦虑及心身症状，将治疗前后各量表因子分及2周减分率进行Pearson相关分析，评价PSSS与其他量表的等效性。结果：治疗前后，PSSS评分与PHQ-9、GAD-7、PHQ-15评分均呈显著正相关（均r>0，P<0.001）；PSSS评分减分率与PHQ-9、GAD-7及PHQ-15评分减分率也均呈显著正相关（均r>0，P<0.001）；PSSS与PHQ-9、GAD-7、PHQ-15评估抑郁、焦虑及心身症状的治疗有效性（减分率≥50%）相比，差异均无统计学意义（均P>0.05）。结论：PSSS可有效评估抑郁发作患者的抑郁、焦虑和心身症状的严重程度，并可作为疗效的评价工具。

Objective: To use the Psychosomatic Symptoms Scale(PSSS), the 9-item Patient Health Questionnaire(PHQ-9), the Generalized Anxiety Disorder Scale(GAD-7), and the Patient Health Questionnaire Somatic Symptoms Group Scale(PHQ-15) to evaluate patients with depressive episode to explore the efficacy of PSSS in assessing depression, anxiety, and psychosomatic symptoms. Methods: A total of 193 patients with depressive episode were selected. The depressive symptoms, anxiety symptoms and somatic symptom were assessed by PSSS, PHQ-9, GAD-7 and PHQ-15 on the enrollment day and 2 weekends, respectively. Pearson correlation analysis was performed on the score of each scale and 2-week reduction rate before and after treatment to evaluate the equivalence between PSSS and other scales. Results: Before and after treatment, PSSS scores were significantly positively correlated with PHQ-9, GAD-7 and PHQ-15 scores(P<0.001); There was a significant positive correlation between the reduction rate of PSSS scores and PHQ-9, GAD-7 and PHQ-15 scores(P<0.001); Compared with PHQ-9, GAD-7 and PHQ-15 in the evaluation of the efficacy of depression, anxiety and somatic symptoms(reduction rate ≥ 50%), there was no statistical significance in PSSS(P>0.05). Conclusion: The PSSS can be used as a tool to evaluate the severity of depression, anxiety and psychosomatic symptoms in patients with depressive episode.

参考文献：

[1] LI L,PENG T,LIU R,et al.Development of the psychosomatic symptom scale(PSSS) and assessment of its reliability and validity in general hospital patients in China[J].Gen Hosp Psychiatry,2020,64:1-8.
[2] KROENKE K,SPRITZER R L,WILLIAMS J B.The PHQ-9:validity of a brief depression severity measure[J].J Gen Intern Med,2001,16(9):606-613.
[3] SPRITZER R L,KROENKE K,WILLIAMS J B,et al.A brief measure for assessing generalized anxiety disorder:the GAD-7[J].Arch Intern Med,2005,166(10):1092-1097.
[4] KROENKE K,SPRITZER R L,WILLIAMS J B.The PHQ-15:validity of a new measure for evaluating the severity of somaticsymptoms[J].Psychosom Med,2002,64(2):258-266.
[5] 谭靓靓,孙楠,杨莉,等.综合性医院心理精神科住院患者心身症状的临床研究[J].东南大学学报(医学版),2020,39(5):647-651.
[6] KROENKE K,SPRITZER R L.The PHQ-9:a new depression diagnostic and severity measure[J].Psychiatric annals SLACK Incorporated,2002,32(9):509-515.
[7] FERREIRA M F,CASTANHEIRA L,SEBASTIAO A M,et al.Depression assessment in clinical trials and pre-clinical tests:a critical review[J].Curr Top Med Chem,2018,18(19):1677-1703.
[8] 闵宝权,周爱红,梁丰,等.病人健康问卷抑郁自评量表(PHQ-9)的临床应用[J].神经疾病和精神卫生,2013,13(6):569-572.
[9] TOUSSAINT A,HUSING P,GUMZ A,et al.Sensitivity to change and minimal clinically important difference of the 7-item Generalized Anxiety Disorder Questionnaire(GAD-7)[J].J Affect Disord,2020,265:395-401.
[10] KROENKE K,SPRITZER R L,WILLIAMS J B,et al.The Patient Health Questionnaire Somatic,Anxiety,and Depressive Symptom Scales:a systematic review[J].Gen Hosp Psychiatry,2010,32(4):345-359.
[11] 樊欣娜,张晶,陈金良,等.正念减压治疗对心身症状障碍患者的疗效研究[J].东南大学学报(医学版),2020,39(5):629-633.
[12] LYOO Y C,JU S,KIM E,et al.The patient health questionnaire-15 and its abbreviated version as screening tools for depression in Korean college and graduate students[J].Compr Psychiatry,2014,55(3):743-748.
[13] GASPERSZ R,LAMERS F,KENT J M,et al.Longitudinal predictive validity of the DSM-5 anxious distress specifier for clinical outcomes in a large Cohort of patients with major depressive disorder[J].J Clin Psychiatry,2017,78(2):207-213.
[14] SUH S.Stories to be told:Korean doctors between hwa-byung(fire-illness) and depression,1970-2011[J].Cult Med Psychiatry,2013,37(1):81-104.
[15] KATON W,KLEINMAN A,ROSEN G.Depression and somatization:a review part I[J].Am J Med,1982,72(1):127-135.
[16] HUNG C I,WENG L J,SU Y J,et al.Depression and somatic symptoms scale:a new scale with both depression and somatic symptoms emphasized[J].Psychiatry Clin Neurosci,2006,60(6):700-708.
[17] GROVER S,SAHOO S,CHAKRABARTI S,et al.Anxiety and somatic symptoms among elderly patients with depression[J].Asian J Psychiatry,2019,41:66-72.

服务与反馈：

【文章下载】【发表评论】【查看评论】【加入收藏】

提示：您还未登录，请登录！点此登录